Tosoni Alicia, Galvani Linda, Di Nunno Vincenzo, Gatto Lidia, Bartolini Stefania, Aprile Marta, D'Angelo Elisa, Pasquini Ernesto, Baietti Anna Maria, Franceschi Enrico
Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
Department of Experimental, Diagnostic & Specialty Medicine, University of Bologna, 40138 Bologna, Italy.
Cancers (Basel). 2024 Oct 22;16(21):3556. doi: 10.3390/cancers16213556.
Human papilloma virus (HPV) infection is responsible for 4.5% of cancers worldwide, i.e., for around 630,000 new cases per year. Around 38,000 cases per year of HPV-related cancers arise in the head and neck region, of which 21,000 cases are oropharyngeal squamous cell carcinomas (OPSCCs), with an increasing frequency in high-income countries. In our work, we aimed to collect the available evidence about the awareness of the relation between HPV infection and head and neck cancer among patients and practitioners. This review was based on all available prospective and retrospective studies, case reports, and review articles published up to May 2024 in PubMed. The search keywords used included "human papilloma virus" plus "head and neck cancer", "awareness", "infection", "vaccination", "awareness in patients and practitioners", "oropharyngeal squamous cell carcinoma", "HPV16-18", "HPV awareness", "cervical cancer". In the U.S.A., with more than 150.00 participants interviewed through different studies, the identification of HPV infection as a risk factor for head and neck cancer (HNC) was made by only 12-39% of the participants. Similar conclusions were drawn from European studies in which only 10-52% of the participants recognized HPV as a risk factor for HNC. HPV-related HNC awareness in health care providers and medical/dental students showed a high variability among studies, being otolaryngology and dental sciences specialists the most conscious in comparison to general practitioners, who demonstrated a low level of awareness. There is a dangerous lack of awareness about HPV infection and its potential role in HNC among both general populations and health care practitioners. A great effort should be made to increase awareness in both practitioners and the general population on this topic, also aiming to increase the HPV vaccination coverage.
人乳头瘤病毒(HPV)感染导致全球4.5%的癌症,即每年约63万例新发病例。每年约有3.8万例HPV相关癌症发生在头颈部,其中2.1万例为口咽鳞状细胞癌(OPSCC),在高收入国家的发病率呈上升趋势。在我们的研究中,我们旨在收集关于患者和从业者对HPV感染与头颈癌之间关系的认识的现有证据。本综述基于截至2024年5月在PubMed上发表的所有可用的前瞻性和回顾性研究、病例报告及综述文章。使用的搜索关键词包括“人乳头瘤病毒”加“头颈癌”、“认识”、“感染”、“疫苗接种”、“患者和从业者的认识”、“口咽鳞状细胞癌”、“HPV16 - 18”、“HPV认识”、“宫颈癌”。在美国,通过不同研究采访了超过15000名参与者,只有12% - 39%的参与者将HPV感染识别为头颈癌(HNC)的危险因素。欧洲的研究也得出了类似结论,其中只有10% - 52%的参与者认识到HPV是HNC的危险因素。医疗保健提供者以及医学/牙科学生对HPV相关HNC的认识在不同研究中差异很大,与认识水平较低的全科医生相比,耳鼻喉科和牙科科学专家的认识最为深刻。普通人群和医疗保健从业者对HPV感染及其在HNC中的潜在作用都严重缺乏认识。应做出巨大努力,提高从业者和普通人群对这一主题的认识,同时也旨在提高HPV疫苗接种覆盖率。